Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2002
04/18/2002US20020045757 Compound and process for producing beta-adrenergic receptor agonist
04/18/2002US20020045754 Preparation of aryl- or heterroaryl-substituted aminoaryl-pyridines and pyrimidines using Grignard reagents and protected aminoarylboronic acids.
04/18/2002US20020045751 Thyromimetic organic compounds
04/18/2002US20020045749 Antibacterial agents
04/18/2002US20020045648 Therapeutic compositions comprising excess enantiomer
04/18/2002US20020045642 Antiinflammatory, -arthritic and -emetic agents; central nervous system disorders; Parkinson's disease; antidepressants; psychological disorders; anxiolytic agents; antagonists of substance P receptors
04/18/2002US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/18/2002US20020045618 Heteroaryl diazacycloalkanes, their preparation and use
04/18/2002US20020045550 Uracil substituted phenyl sulfamoyl carboxamides
04/18/2002DE10122447A1 Biphenylcarboxamide Biphenylcarboxamides
04/18/2002DE10048716A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site
04/18/2002DE10046934A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren A process for the fermentative production of non-proteinogenic L-amino acids
04/18/2002CA2765409A1 Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
04/18/2002CA2425649A1 Nitroderivatives as drugs for diseases having an inflammatory basis
04/18/2002CA2425540A1 Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride
04/18/2002CA2424107A1 Sulfonylguanidines
04/17/2002EP1196620A1 Method for oxidating organic compounds
04/17/2002EP1196400A1 Amino-alkyl derivatives
04/17/2002EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
04/17/2002EP1196389A1 N-heterocyclic derivatives with neuronal activity
04/17/2002EP1196388A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
04/17/2002EP1196387A1 Azo amino acid derivatives for the treatment of neurological diseases
04/17/2002EP1196386A2 N-substituted glycine derivatives
04/17/2002EP1196385A1 Beta-amino acid derivatives for the treatment of neurological diseases
04/17/2002EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
04/17/2002EP1095037B1 process of synthesis of 5-methoxy- 2- (4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl]sulfinyl-1h-benzimidazole
04/17/2002EP0871362B1 Synergistic insecticide mixtures
04/17/2002EP0851858B1 Substituted 2-phenylpyridines as herbicides
04/17/2002CN1345314A Amine derivatives as protease inhibitors
04/17/2002CN1345312A Dibenzoazulene derivatives for treating thrombosis, osteoporosis arteriosclerosis
04/17/2002CN1345309A Diaryl derivatives and their use as medicaments
04/17/2002CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors
04/17/2002CN1345304A Substituted aniline compounds
04/17/2002CN1345300A Processes for preparing pesticidal intormediates
04/17/2002CN1344801A Method for production of non-proteinogen L-amino acid by fermentation
04/17/2002CN1082949C Process for converting 2,4-dichloropyridines into 2-aryloxy-4-chloropyridines
04/17/2002CN1082945C Alkoxiyimino acetamide
04/16/2002US6372932 Porous solid products of 1,3,5-benzenetricarboxylate and metal ions
04/16/2002US6372908 Preparation of vanadium antimonate based catalyst using sno2h2o
04/16/2002US6372779 Anthracene derivatives with carbamoyl groups, amido groups, urea groups and sulfonamide groups
04/16/2002US6372778 Sulfonamide inhibitors of aspartyl protease
04/16/2002US6372768 2-aminopyridines containing fused ring substituents
04/16/2002US6372767 Benzanilides as potassium channel openers
04/16/2002US6372766 Substituted 2-(2′-pyridyloxy)phenylacetamides, as fungicides and pesticides
04/16/2002US6372762 Heterocyclic compounds for nervous system disorders
04/16/2002US6371993 Hair dyes
04/16/2002CA2087592C Ferroelectric liquid crystal compositions containing chiral haloalkoxy tail units
04/16/2002CA2087414C Arylcycloalkyl derivatives their production and their use
04/11/2002WO2002030159A1 Organic electroluminescent devices
04/11/2002WO2002029021A2 Biotechnological method for preparing carboxylic acids with a hydroxy-nitrogen heterocycle
04/11/2002WO2002028836A1 Novel crystalline forms of a factor xa inhibitor
04/11/2002WO2002028835A1 Benzamide compounds as apo b secretion inhibitors
04/11/2002WO2002028825A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
04/11/2002WO2002028820A1 Nitroso diphenylamine derivatives
04/11/2002WO2002028805A2 Process for the co-oligomerisation of ethylene and alpha olefins
04/11/2002WO2002028392A1 Remedies for brain circulatory disturbances
04/11/2002WO2002028182A1 Phenylpropynyloxypyridine herbicides
04/11/2002WO2002000683A3 Novel chain-breaking antioxidants
04/11/2002WO2001085671A3 Anthranyl amides and their use as medicaments
04/11/2002WO2001077079A3 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
04/11/2002US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
04/11/2002US20020042512 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators
04/11/2002US20020042414 Antiallergens
04/11/2002US20020042399 Analgesics; skin disorders
04/11/2002US20020042381 Antilipemic agents
04/11/2002DE10141565A1 Cyclobutanone compounds useful in liquid crystal media, especially for plasma-addressed displays, comprises substituted trans-cyclohexylene, p-phenylene and-or other cyclic groups,
04/11/2002CA2425097A1 Benzamide compounds as apo b secretion inhibitors
04/11/2002CA2424801A1 Process for the co-oligomerisation of ethylene and alpha olefins
04/11/2002CA2424684A1 Nitroso diphenylamine derivatives
04/11/2002CA2423883A1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
04/11/2002CA2422675A1 Phenylpropynyloxypyridine herbicides
04/10/2002EP1195372A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity
04/10/2002EP1194447A2 Novel potassium channels and genes encoding these potassium channels
04/10/2002EP1194428A1 Heteroaryl protease inhibitors and diagnostic imaging agents
04/10/2002EP1194427A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
04/10/2002EP1194419A1 Method for producing 2-heterocyclyl methyl benzoic acid derivatives
04/10/2002EP1194406A1 Phenetyl-thiourea compounds for treating hiv infections
04/10/2002EP1194401A1 Diacylhydrazine derivatives
04/10/2002EP1194149A1 Cyclohexenyl-ethyl-thiourea compounds and use
04/10/2002EP1194143A2 Il-8 receptor antagonists
04/10/2002EP1194135A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
04/10/2002EP1042323B1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them
04/10/2002EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
04/10/2002EP0882716B1 Pyridinecarboxamide derivatives
04/10/2002CN1344253A Low-dusting, flowable aminopyridine products
04/10/2002CN1344249A 酰胺衍生物 Amide derivatives
04/10/2002CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
04/10/2002CN1344243A Liquid crystal compounds
04/10/2002CN1344157A Use of certain offinity NMDA antagonists as antidepressants
04/10/2002CN1343664A Process for synthesizing trident pyridinimine ligand
04/10/2002CN1082508C antivirally active heterocyclic azahexane derivatives
04/09/2002USRE37650 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
04/09/2002US6369275 Enzyme inhibitors for cyclooxygenace
04/09/2002US6369231 Process for preparation of 2-chloropyridine
04/09/2002US6369230 Displacement and quaterinization and basic catalyst
04/09/2002US6369229 Pyridylalanine derivatives
04/09/2002US6369227 Thrombin or factor Xa inhibitors
04/09/2002US6369226 Substituted benzamide inhibitors of rhinovirus 3C protease
04/09/2002US6369111 Fungicides
04/09/2002US6369083 2-methoxyimino-2 (pyrinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring